RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness

Richard T Jennings, Monika Strengert, Patti Hayes, Jamel El-Benna, Cord Herbert Brakebusch, Malgorzata Kubica, Ulla G Knaus

23 Citationer (Scopus)

Abstract

Neutrophil responses are central to host protection and inflammation. Neutrophil activation follows a 2-stepprocess in which priming amplifies responses to activating stimuli. Priming isessential for life span extension, chemotaxis, and respiratory burst activity. Here we show that the cytoskeletal organizer RhoA suppresses neutro phil priming via formins. Premature granule exocytosis in Rho-deficient neutrophils activated numerous signaling pathways and amplified superoxide generation. Deletion of Rho altered front-to-back coordination by simultaneously increasing uropod elongation, leading edge formation, and random migration. Concomitant negative and positive regulation of β2 integrin-independent and β2 integrin-dependent migration, respectively, reveal Rho as a key decision point in the neutrophil response to discrete chemotactic agents. Although even restricted influx of Rho-deficient hyperactive neutrophils exacerbated lipopolysaccharide-mediated lung injury, deleting Rho in innate immune cells was highly protective in influenza A virus infection. Hence, Rho is a key regulator of disease progression by maintaining neutrophil quiescence and suppressing hyperresponsiveness.

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind123
Udgave nummer23
Sider (fra-til)3635-45
Antal sider11
ISSN0006-4971
DOI
StatusUdgivet - 5 jun. 2014

Fingeraftryk

Dyk ned i forskningsemnerne om 'RhoA determines disease progression by controlling neutrophil motility and restricting hyperresponsiveness'. Sammen danner de et unikt fingeraftryk.

Citationsformater